| scholarly article | Q13442814 |
| P50 | author | José María Ordovás | Q6454858 |
| Serkalem Demissie | Q37389793 | ||
| L. Adrienne Cupples | Q37638868 | ||
| Katherine L. Tucker | Q38802211 | ||
| Dolores Corella Piquer | Q47101238 | ||
| Chao-Qiang Lai | Q87807530 | ||
| P2093 | author name string | Laurence D Parnell | |
| Xian Adiconis | |||
| Yueping Zhu | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| fatty acid | Q61476 | ||
| triglyceride | Q186319 | ||
| P304 | page(s) | 2062-2070 | |
| P577 | publication date | 2006-04-24 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study | |
| P478 | volume | 113 |
| Q35745829 | A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes. |
| Q64256630 | A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome |
| Q33711837 | A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies. |
| Q46053848 | A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN. |
| Q28302513 | APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population |
| Q57336930 | APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study |
| Q36231656 | APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial |
| Q28277677 | Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology |
| Q37421221 | Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults |
| Q57336937 | Apolipoprotein A5: an emerging paradigm for genetic associations and interactions in lipoprotein and cardiovascular research |
| Q47144648 | Apolipoprotein E gene polymorphism modifies fasting total cholesterol concentrations in response to replacement of dietary saturated with monounsaturated fatty acids in adults at moderate cardiovascular disease risk |
| Q35591965 | Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men. |
| Q37291712 | Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes |
| Q38936923 | Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor |
| Q34180234 | Atherogenic dyslipidemia: cardiovascular risk and dietary intervention |
| Q28286349 | Clinical significance of apolipoprotein A5 |
| Q37682045 | Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes |
| Q38679643 | Detection of gene-environment interactions in a family-based population using SCAD. |
| Q84906931 | Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women |
| Q36994072 | Dyslipidemia in obesity: mechanisms and potential targets |
| Q36975580 | Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women |
| Q33574568 | Effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism |
| Q57336571 | El polimorfismo −1131 T>C del promotor del gen de la apolipoproteína A5 altera la unión de NRF2 (nuclear respiratory factor-2) y disminuye la actividad del promotor |
| Q37271503 | Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women |
| Q26741557 | Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management |
| Q34458072 | Genetics of the Framingham Heart Study population |
| Q55417514 | Genomic Influence in the Prevention of Cardiovascular Diseases with a Sterol-Based Treatment. |
| Q42869880 | Heterogeneous Postprandial Lipoprotein Responses in the Metabolic Syndrome, and Response to Fenofibrate Therapy |
| Q28248690 | Impact of apolipoprotein A5 variants on statin treatment efficacy |
| Q33293923 | Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation. |
| Q57316305 | Interaction between diets, polymorphisms and plasma lipid levels |
| Q57316299 | Interactions between Dietary Fat Intake and FASN Genetic Variation Influence LDL Peak Particle Diameter |
| Q35598019 | Interactions between dietary n-3 fatty acids and genetic variants and risk of disease |
| Q34188057 | Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease. |
| Q59450218 | La grasa saturada en la dieta disminuye la expresión hepática de APOA5 en ratones deficientes en apo E |
| Q38195644 | New criteria for supplementation of selected micronutrients in the era of nutrigenetics and nutrigenomics |
| Q57049129 | Nutrigenetic Contributions to Dyslipidemia: A Focus on Physiologically Relevant Pathways of Lipid and Lipoprotein Metabolism |
| Q37730893 | Nutrigenetics and nutrigenomics of atherosclerosis |
| Q37401949 | Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? |
| Q38539222 | Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era. |
| Q37961647 | Nutrigenetics of the lipoprotein metabolism |
| Q64892364 | Nutrigenetics, epigenetics and gestational diabetes: consequences in mother and child. |
| Q33605821 | Nutrigenomics in cardiovascular medicine |
| Q36558565 | Nutrigenomics: a case for the common soil between cardiovascular disease and cancer |
| Q38023791 | Nutritional status, genetic susceptibility, and insulin resistance--important precedents to atherosclerosis. |
| Q36805381 | Omega-3 fatty acids, polymorphisms and lipid related cardiovascular disease risk factors in the Inuit population |
| Q37209161 | Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis. |
| Q37271474 | Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia |
| Q34206069 | Rat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet |
| Q36818981 | Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase |
| Q92178345 | Role of Personalized Nutrition in Chronic-Degenerative Diseases |
| Q61458441 | Saturated Fat: Part of a Healthy Diet |
| Q36319853 | Serum vitamins A and E as modifiers of lipid trait genetics in the National Health and Nutrition Examination Surveys as part of the Population Architecture using Genomics and Epidemiology (PAGE) study |
| Q35104849 | Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach |
| Q21135510 | The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site |
| Q28306572 | The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study |
| Q39029674 | The integration of epigenetics and genetics in nutrition research for CVD risk factors. |
| Q35907312 | Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol |
| Q47319141 | n-3 Fatty acids inhibit transcription of human IL-13: implications for development of T helper type 2 immune responses |
Search more.